These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13873301)

  • 1. Effects of decarboxylase inhibition on the biosynthesis of brain monoamines.
    BRODIE BB; KUNTZMAN R; HIRSCH CW; COSTA E
    Life Sci (1962); 1962 Mar; 1():81-4. PubMed ID: 13873301
    [No Abstract]   [Full Text] [Related]  

  • 2. Actions of the decarboxylase inhibitor, alpha-methyl-3,4-dihydroxyphenylalanine, in the dog.
    GOLDBERG LI; DACOSTA FM; OZAKI M
    Nature; 1960 Nov; 188():502-4. PubMed ID: 13706461
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of brain glutamic decarboxylase by running fit-inducing substances.
    NISHIZAWA Y; KODAMA T; YAMANAKA T
    J Vitaminol (Kyoto); 1959 Jun; 5():111-6. PubMed ID: 14427322
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro reversal of glutamate decarboxylase inhibition induced by 1,1-dimethylhydrazine.
    MEDINA MA; BRAYMER HD; REEVES JL
    J Neurochem; 1962; 9():307-12. PubMed ID: 14472005
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].
    Bartholini G; Pletscher A; Burkard WP
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR170-2. PubMed ID: 5588156
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.
    Bartholini G; Burkard WP; Pletscher A
    Nature; 1967 Aug; 215(5103):852-3. PubMed ID: 6049735
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a new decarboxylase inhibitor on endogenous monoamines.
    PLETSCHER A; GEY KF
    Biochem Pharmacol; 1963 Mar; 12():223-8. PubMed ID: 13944044
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of leucine decarboxylase by thiol-binding reagents.
    SUTTON CR; KING HK
    Arch Biochem Biophys; 1962 Feb; 96():360-70. PubMed ID: 13918558
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
    HANSSON E; FLEMING RM; CLARK WG
    Int J Neuropharmacol; 1964 May; 3():177-88. PubMed ID: 14336525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral glutamic acid decarboxylase and pyridoxal-5-phosphate hydrazones].
    GONNARD P; FENARD S
    J Neurochem; 1962; 9():135-42. PubMed ID: 13900161
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the inhibition of L-glutamic acid and L-DOPA decarboxylase by D-cycloserine and other isoxazolidones].
    DENGLER HJ; RAUCHS E; RUMMEL W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 243():366-81. PubMed ID: 13885421
    [No Abstract]   [Full Text] [Related]  

  • 12. Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphate.
    HANDSCHUMACHER RE
    J Biol Chem; 1960 Oct; 235():2917-9. PubMed ID: 13711194
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracil.
    HANDSCHUMACHER RE; PASTERNAK CA
    Biochim Biophys Acta; 1958 Nov; 30(2):451-2. PubMed ID: 13607480
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of diaminopimelic acid decarboxylase activity in Mycobacterium tuberculosis by isonicotinic acid hydrazide.
    WILLETT HP
    Proc Soc Exp Biol Med; 1958 Oct; 99(1):177-9. PubMed ID: 13601806
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition.
    Carlsson A; Lindqvist M
    J Pharm Pharmacol; 1970 Sep; 22(9):726-7. PubMed ID: 4394774
    [No Abstract]   [Full Text] [Related]  

  • 16. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 17. INHIBITION OF CEREBRAL DECARBOXYLASE AND BEHAVIOUR.
    PLETSCHER A; PRADAM DA; STEINER FA
    Int J Neuropharmacol; 1964 Dec; 3():550-64. PubMed ID: 14344493
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase and decarboxylase inhibitors as antihypertensive agents.
    GILLESPIE L; SJOERDSMA A
    Med Clin North Am; 1961 Mar; 45():421-8. PubMed ID: 13705342
    [No Abstract]   [Full Text] [Related]  

  • 19. [Repression of meso-alpha, epsilon-diaminopimelic acid decarboxylase by L-lysine in Escherichia coli].
    PATTE JC; LOVINY T; COHEN GN
    Biochim Biophys Acta; 1962 Apr; 58():359-60. PubMed ID: 14484389
    [No Abstract]   [Full Text] [Related]  

  • 20. Decarboxylase inhibitors in the treatment of hypertension.
    BREST AN; MOYER JH
    Am J Cardiol; 1962 Jan; 9():116-9. PubMed ID: 13872878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.